截然不同的5-HT受体亚型通过血清素和迷幻药物DOI调节闭层刺激性
Tanner L Anderson1, Jack V Keady2, Judy Songrady2
1University of Kentucky, College of Medicine, Department of Neuroscience, Lexington, KY 40536, United States.
Progress in neurobiology
|September 1, 2024
概括
闭膜 (CLA) 中的色素 (5-HT) 受体调节对迷幻药物的反应. 5-HT2C受体,而不是5-HT2A,调解这些对CLA-ACC电路活性的影响.
科学领域:
- 神经科学是一个神经科学.
- 神经药理学神经药理学
- 分子生物学分子生物学
背景情况:
- 闭关体 (CLA) 在迷幻反应中发挥作用.
- 血清激素 (5-HT) 受体是迷幻药物的主要点.
- 目前尚不清楚CLA与血清素受体的相互作用.
研究的目的:
- 为了研究CLA中血清素受体亚型的表达.
- 为了确定血清素和迷幻药对CLA神经元刺激性的影响.
- 阐明涉及CLA对迷幻药物反应的特定血清素受体亚型.
主要方法:
- 所有已知的5-HT受体亚型的特征性CLA表达.
- 在皮层投射的CLA神经元上进行了电生理学记录.
- 应用了5-HT和DOI (一种迷幻药),并评估了对突触电流的影响.
主要成果:
- 氨基酸富含5-HT2C受体,主要存在于谷氨酸性神经元上.
- 5-HT抑制,而DOI刺激,在CLA-ACC神经元中的刺激后突触电流 (EPSCs).
- 抑制5-HT2C受体,而不是5-HT2A,逆转了5-HT和DOI的影响.
结论:
- 特定的5-HT受体亚型调节了CLA刺激性.
- 5-HT2C受体,而不是5-HT2A,在CLA-ACC电路中对幻觉药物的作用至关重要.
- 挑战了5-HT2A在这种电路内的迷幻诱导的谷氨酸反应中的既定作用.
相关概念视频
CNS Stimulants: Psychedelic Agents
132
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
132
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
225
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
225
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Cholinergic Receptors: Muscarinic
2.0K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.0K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205


